DB17239ExperimentalProtein Based Therapies
Cantuzumab mertansine: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Mucin-1
- Also known as
- Immunoglobulin g1, anti-(mucin canag) (human-mouse monoclonal c242 heavy chain), disulfide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-mercapto-1-oxopropyl)maytansine (1:4) · Immunoglobulin g1, anti-(mucin canag) (human-mouse monoclonal c242 heavy chain), disulphide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-mercapto-1-oxopropyl)maytansine (1:4) · Immunoglobulin g1, anti-(mucin canag) human-mouse monoclonal c242 heavy chain), disulfide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-sulfanylpropanoyl)maytansine · Immunoglobulin g1, anti-(mucin canag) human-mouse monoclonal c242 heavy chain), disulphide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-sulphanylpropanoyl)maytansine · Maytansine, n2-deacetyl-n2-(3-mercapto-1-oxopropyl)-, conjugated humanized c242 monoclonal antibody
- Code names
- HUC-242-DM1 · SB-408075
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Cantuzumab mertansine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account